Pharma Innovation Increasingly Viable In Middle-Income Countries
This article was originally published in PharmAsia News
Executive Summary
R&D spending grew 455% among PhRMA members in Asia between 2005 and 2010, compared to increases of 112% in Latin America and 303% in India, according to IFPMA survey.